United Therapeutics | UTHR - Net Income



United Therapeutics reported $309.5M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Amarin USD -15697000 32.92M Mar/2025
Ardelyx USD -19080000 23.72M Jun/2025
Baxter International USD 91M 35M Jun/2025
Bayer EUR -199000000 1.5B Jun/2025
Biogen USD 634.8M 394.3M Jun/2025
BioMarin Pharmaceutical USD 240.53M 54.85M Jun/2025
Gilead Sciences USD 1.96B 645M Jun/2025
GlaxoSmithKline GBP 1.44B 181M Jun/2025
Halozyme Therapeutics USD 165.16M 47.06M Jun/2025
Insmed USD -321686000 65.1M Jun/2025
Ionis Pharmaceuticals USD 123.55M 270.49M Jun/2025
J&J USD 5.54B 5.46B Jun/2025
Moderna USD -825000000 146M Jun/2025
Pfizer USD 2.91B 58M Jun/2025
PTC Therapeutics USD -64849000 931.41M Jun/2025
Regeneron Pharmaceuticals USD 1.39B 582.9M Jun/2025
Sarepta Therapeutics USD 196.89M 644.4M Jun/2025
Teva Pharmaceutical Industries USD 282M 68M Jun/2025
United Therapeutics USD 309.5M 12.7M Jun/2025
Vertex Pharmaceuticals USD 1.03B 386.6M Jun/2025